Nurses are emerging as key figures in government policy-making, particularly in decisions about healthcare spending and delivery. According to Dr. Frances Hughes, CEO of the International Council of Nurses, research from 40 to 50 countries shows that reducing the role of registered nurses and replacing them with less-skilled workers leads to higher patient mortality. Studies demonstrate that for every 10% increase in the number of nurses with a bachelor’s degree, patient mortality is reduced by 7%.
Healthcare systems globally face mounting costs, and nurses are often targeted for budget cuts because they represent the largest item in salaries on hospital spreadsheets. However, evidence-based approaches show that deprioritizing nursing is counterproductive. According to Hughes, the issue is not whether nurses can perform clinical work—they can—but rather gaining recognition from government officials and insurers who must understand the relationship between nurse staffing levels and patient outcomes. Private insurers in the United States have begun reimbursing nurse-practitioners for services at parity with physicians, signaling a shift in how the healthcare system values nursing expertise.
The ethics of involuntary psychiatric care became another focal point, particularly regarding treatment for severe anorexia nervosa. Dr. Sacha Kendall Jamieson, a researcher in palliative and acute care, explained that involuntary commitment decisions are complex and vary based on disease progression, patient insight, and available treatment options. For adults with severe, chronic anorexia nervosa who have exhausted treatment options, clinicians sometimes determine that involuntary hospitalization is no longer justified. Evidence shows that earlier treatment intervention produces better outcomes, but for long-duration cases, the professional community lacks consensus on when forced treatment is ethically defensible.
Mitochondrial disease, affecting approximately 120,000 Australians, represents another healthcare challenge drawing attention to policy needs. The disease occurs when mitochondria fail to produce sufficient energy for cells, potentially affecting any organ system at any age. Sean Murray, CEO of the Australian Mitochondrial Disease Foundation, noted that while there is no cure, promising drugs are currently in clinical trials, providing hope for improved treatment options in coming years.
This article is an AI-assisted summary. All facts and figures are drawn from the original report: https://www.uts.edu.au/news/2016/09/nurses-and-policy-involuntary-care-and-stay-bed-day